期刊文献+

p53基因BstUⅠ位点多态性与非小细胞肺癌易感性及放射敏感性的相关性研究 被引量:7

Association of polymorphism of codon 72 in p53 gene with susceptibility and radiosensitivity of non-small cell lung cancer in Chinese population
暂未订购
导出
摘要 背景与目的肺癌是世界上发病率和死亡率增长较快的恶性肿瘤。近几年来随着分子生物学的蓬勃发展,人们对疾病的认识达到了基因水平。通过分子生物学方法发现某一基因与肺癌之间的关联性并加以利用,为早期诊断及治疗肺癌提供了一个新的思路。本研究拟探讨p53肿瘤抑制基因BstUⅠ位点多态性与非小细胞肺癌(NSCLC)易感性及放射敏感性的相关性。方法采用PCRRFLP方法检测50例NSCLC患者及50例健康对照p53基因序列中的BstUⅠ位点单核苷酸多态性(SNP)。并采用病例对照方法分析p53基因BstUⅠ位点的多态性与肺癌的易感性,以及NSCLC患者p53基因BstUⅠ位点的多态性与放疗疗效的相关性。结果不同p53基因BstUⅠ基因型的NSCLC患者对放疗的有效率不尽相同。杂合子(A1/A2)基因型的患者对放疗的有效率低,仅为25.0%,而纯合子(A1/A1,A2/A2)基因型的患者对放疗的有效率较高,分别为71.4%和70.0%,三者之间的差异有显著性(χ2=9.2,P<0.05)。肺癌组的A1/A1、A1/A2及A2/A2基因型频率分别为28.0%、32.0%及40.0%,对照组为32.0%、42.0%及26.0%,但两组间纯合子的频率差异并无统计学意义(P均>0.05),并且未观察到p53基因BstUⅠ的多态性与NSCLC易感性有密切的相关关系。结论p53基因BstUⅠ位点多态性可能与NSCLC发生无关,但NSCLC患者的p53基因BstUⅠSNP可能与放射敏感性有关。 Background and objective Lung cancer is one of the most common cancers worldwide and its mortality rate has increased year after year. Molecular biology has contributed to make people's understanding to the disease at the gene level. A new idea will be given to the early diagnosis and treatment for lung cancer with the method of molecular biology which can be used to find the association between some genes and lung cancer. The aim of this study is to evaluate the relationship between polymorphism of codon 72 (BstUⅠ single nucleotide polymorphism, BstUⅠ SNP) in p53 gene and susceptibility and radiosensitivity of non-small cell lung cancer (NSCLC) in Chinese population. Methods The BstUⅠ single nucleotide polymorphic sites at condon 72 in exon 4 of p53 gene in 50 patients with NSCLC as well as 50 healthy controls were inspected by polymerase chain reaction-restricted fragment length polymorphism assay and the relationship between BstUⅠ SNP and susceptibility and radiosensitivity of NSCLC was analysed by case-control test. Results The allelic distribution of the three genotypes (A1/A1, A1/A2, A2/A2) in healthy controls was 32. 0%, 42.0% and 26.0% respectively, which differed slightly from that of lung cancer patients, which was 28.0%, 32.0% and 40. 0%. These allelic and genotype differences between control and lung cancer groups (A1/A1 OR=0.83, 95% CI 0. 36-1.27 and A2/A2 OR=1. 0, 95% CI 0.82-4. 42) were insignificant. The patients with A1/A1 or A2/A2 genotype were sensitive to radiotherapy and the patients with A1/A2 were not sensitive to radiotherapy (χ^2 =9.2, P〈0.05), the effective rate to radiotherapy were 71.4%, 70. 0% and 25.0% respectively. Conclusion There is no significant relationship between the BstUⅠ SNP in p53 and susceptibility in NSCLC. The p53 BstUⅠ SNP is closely associated with radiosensitivity of NSCLC in the Northern Chinese population.
出处 《中国肺癌杂志》 CAS 2006年第2期173-176,共4页 Chinese Journal of Lung Cancer
基金 吉林省科技厅社会发展基金(No.92226000)资助~~
关键词 单核苷酸多态性 非小细胞肺癌 P53基因 放射敏感性 易感性 Single nucleotide polymorphism Non-small cell lung cancer p53 gene Radiosensitivity Susceptibility
  • 相关文献

参考文献10

  • 1Haupt Y,Maya R,Kazaz A, et al. Mdm2 promotes the rapid degradation of p53. Nature,1997,387(6630):296-299.
  • 2Sjalander A,Birgander R,Hallmans G,et al. p53 polymorphisms and haplotypes in breast cancer. Carcinogenesis, 1996, 17(6):1313-1316.
  • 3张健慧,李琰,王瑞,温登瑰,吴明利,何明.中国人食管癌及肺癌发病风险与p53基因多态性[J].中华肿瘤杂志,2003,25(4):365-367. 被引量:30
  • 4Thomas M,Kalita A, Labrecque S,et al. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol,1999,19(2):1092-1100.
  • 5Su L, Sai Y, Fan R, et al. P53 (codon 72) and P21 (codon 31)polymorphisms alter in vivo mRNA expression of p21. Lung Cancer,2003,40(3):259-266.
  • 6Irarrazabal CE, Rojas C, Aracena R, et al. Chilean pilot study on the risk of lung cancer associated with codon 72 polymorphism in the gene of protein p53. Toxicol Lett,2003,144(1):69-76.
  • 7Miller DP,Liu G, De Vivo I, et al. Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk. Cancer Res,2002,62(10):2819-2823.
  • 8Pierce LM, Sivaraman L, Chang W, et al. Relationships of TP53 codon 72 and HRAS1 polymorphisms with lung cancer risk in an ethnically diverse population. Cancer Epidemiol Biomarkers Prey,2000,9(11) : 1199-1204.
  • 9van Heemst D,Mooijaart SP, Beekman M,et al. Variation in the human TP53 gene affects old age survival and cancer mortality.Exp Gerontol,2005,40(1-2):11-15.
  • 10Biros E, Kalina I, Kohut A, et al. Germ line polymorphisms of the tumor suppressor gene p53 and lung cancer. Lung Cancer,2001,31(2-3):157-162.

二级参考文献12

  • 1Soussi T. The p53 tumor suppressor gene: from molecular biology to clinical investigation. Ann N Y Acad Sci, 2000,910:121-137.
  • 2Thomas M, Kalita A, Labrecque S, et al. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol,1999,19:1092-1100.
  • 3Pierce LM, Sivaraman L, Chang W, et al. Relationships of TP53 codon 72 and HRAS1 polymorphisms with lung cancer risk in an ethnically diverse population. Cancer Epidemiol Biomarkers Prey, 2000,9: 1199-1204.
  • 4Fan R, Wu MT, Miller D, et al. The p53 codon 72 polymorphism and lung cancer risk. Cancer Epidemiol Biomatkers Prev, 2000, 9: 1037-1042.
  • 5Peixoto Guimaraes D, Hsin Lu S, Snijders P, et al.Absence of association between HPV DNA, TP53 codon 72 polymorphism, and risk of oesophageal cancer in a high-risk area of China. Cancer Lett, 2001,162:231-235.
  • 6Lee JM, Lee YC, Yang SY, et al. Genetic polymorphisms of p53 and GSTP1, but not NAT2, are associated with susceptibility to squamous-cell carcinoma of the esoohagus. Int J Cancer, 2000,89:458-464.
  • 7Storey A, Thomas M, Kalita A, et al. Role of a p53 polymerphism in the development of human papillomavirus-associated cancer. Nature,1998,393 : 229-234.
  • 8Tandle AT, Sanghvi V, Saranath D. Determination of p53 genotype in oral cancer patients from India. Br J Cancer, 2001,84:739-742.
  • 9O'Connor DP, Kay EW,Leader M, et al. p53 codon 72 polymorphism and human papillomavirus associated skin cancer. J Clin Pathol, 2001,54: 539-542.
  • 10Buller RE, Sood A, Fullenkamp C, et al. The influence of the p53 codon 72 polymorphism on ovarian carcinogenesis and prognosis. Cancer Gene Ther, 1997,4: 239-245.

共引文献29

同被引文献33

引证文献7

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部